Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study.
Antoní TorresAna MotosCatia CillónizAdrián CeccatoLaia Fernández-BaratAlbert GabarrúsJesús Bermejo-MartinRicard FerrerJordi RieraRaquel Pérez-ArnalDario García-GasullaOscar PeñuelasJosé Ángel LorenteDavid de Gonzalo-CalvoRaquel AlmansaRosario MenéndezAndrea PalomequeRosario Amaya VillarJosé M AñónAna Balan MariñoCarme BarberàJosé BarberánAaron Blandino OrtizMaria Victoria BoadoElena Bustamante-MunguiraJesús CaballeroMaría Luisa Cantón-BulnesCristina Carbajales PérezNieves CarbonellMercedes Catalán-GonzálezRaul de FrutosNieves FrancoCristóbal GalbánVíctor D Gumucio-SanguinoMaria Del Carmen de la TorreEmili DíazÁngel EstellaElena GallegoJosé Luis García GarmendiaJosé M GómezArturo HuertaRuth Noemí Jorge GarcíaAna Loza-VázquezJudith Marin-CorralMaría Cruz Martin DelgadoAmalia Martínez de la GándaraIgnacio Martínez VarelaJuan López MessaGuillermo M AlbaicetaMaite NietoMariana Andrea NovoYhivian PeñascoFelipe Pérez-GarcíaJuan Carlos Pozo-LaderasPilar RicartVictor SagredoAngel Sánchez-MirallesSusana Sancho ChinestaMireia Serra-FortunyLorenzo SociasJordi Solé-ViolanFernando Suarez-SipmannLuis Tamayo LomasJosé TrenadoAlejandro ÚbedaLuis Jorge ValdiviaPablo VidalFerran Barbénull nullPublished in: Intensive care medicine (2022)
Corticosteroid in ICU-admitted patients with COVID-19 may be administered based on age, severity, baseline inflammation, and invasive mechanical ventilation. Early administration since symptom onset may prove harmful.